<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-2302293904584925227</id><updated>2011-10-05T02:11:13.576-07:00</updated><category term='cystic fibrosis treatment'/><title type='text'>Cys</title><subtitle type='html'></subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://the-cystic-fibrosis.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><link rel='next' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default?start-index=101&amp;max-results=100'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>309</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6149582634012931593</id><published>2009-09-13T17:36:00.001-07:00</published><updated>2009-09-13T17:36:49.012-07:00</updated><title type='text'>Fibre content of enteral feeds for the older child.</title><summary type='text'> J Hum Nutr Diet. 2009 Oct; 22(5): 414-21Evans S, Daly A, Davies P, Macdonald ABackground: There is currently a lack of clinical data on fibre requirements in UK children. Subsequently, the ideal fibre profile for enteral formulae designed to meet the requirements of older children is unknown. The present study aimed to investigate the effect of fibre supplementation on gastrointestinal function </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6149582634012931593'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6149582634012931593'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/fibre-content-of-enteral-feeds-for.html' title='Fibre content of enteral feeds for the older child.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7983482340645335218</id><published>2009-09-12T15:58:00.001-07:00</published><updated>2009-09-12T15:58:29.545-07:00</updated><title type='text'>Hepatic Segments and Vasculature: Projecting CT Anatomy onto Angiograms.</title><summary type='text'> Radiographics. 2009 Sep 4; Furuta T, Maeda E, Akai H, Hanaoka S, Yoshioka N, Akahane M, Watadani T, Ohtomo KHepatic transarterial interventional therapies such as chemoembolization and radiation embolization are important treatment options for hepatocellular carcinoma. Understanding the anatomy of individual arterial branches and hepatic segments is critical for selecting the correct </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7983482340645335218'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7983482340645335218'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/hepatic-segments-and-vasculature.html' title='Hepatic Segments and Vasculature: Projecting CT Anatomy onto Angiograms.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7478892624496715020</id><published>2009-09-11T17:52:00.001-07:00</published><updated>2009-09-11T17:52:40.749-07:00</updated><title type='text'>The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis.</title><summary type='text'> Hum Reprod. 2009 Sep 3; Watanabe A, Taniguchi F, Izawa M, Suou K, Uegaki T, Takai E, Terakawa N, Harada TBACKGROUND Decreased susceptibility of endometrial tissue to apoptosis may contribute to the pathogenesis of endometriosis. We investigate the role of survivin in the pathophysiology of endometriosis through the ability of ectopic and eutopic endometrial stromal cells (ESCs) to resist </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7478892624496715020'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7478892624496715020'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/role-of-survivin-in-resistance-of.html' title='The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2977636587304627676</id><published>2009-09-10T23:35:00.000-07:00</published><updated>2009-09-10T23:36:49.675-07:00</updated><title type='text'>Detection of pain-related molecules in the subchondral bone of osteoarthritic knees.</title><summary type='text'> Clin Rheumatol. 2009 Sep 3; Ogino S, Sasho T, Nakagawa K, Suzuki M, Yamaguchi S, Higashi M, Takahashi K, Moriya HKnee pain is predominant among osteoarthritis (OA) patients, but the mechanism is poorly understood. We investigated subchondral bone as a source of OA knee pain using immunohistochemistry. Fifteen medial-type OA knees with minimum involvement of the lateral compartment determined by </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2977636587304627676'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2977636587304627676'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/detection-of-pain-related-molecules-in.html' title='Detection of pain-related molecules in the subchondral bone of osteoarthritic knees.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3198175301470504897</id><published>2009-09-10T17:43:00.001-07:00</published><updated>2009-09-10T17:43:52.414-07:00</updated><title type='text'>Completely Laparoscopic Subtotal Pancreatectomy with Splenic Artery Preservation.</title><summary type='text'> J Gastrointest Surg. 2009 Sep 2; Boutros C, Espat NJ, Somasundar PINTRODUCTION: Laparoscopic distal pancreatectomy has emerged as an attractive minimally invasive alternative for selected patients. Although technically challenging, distal pancreatectomy with splenic artery preservation has consistently been correlated with reduced blood loss and perioperative morbidity in multiple studies. </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3198175301470504897'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3198175301470504897'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/completely-laparoscopic-subtotal.html' title='Completely Laparoscopic Subtotal Pancreatectomy with Splenic Artery Preservation.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8461153957257132095</id><published>2009-09-09T23:26:00.001-07:00</published><updated>2009-09-09T23:26:20.026-07:00</updated><title type='text'>Incidental Pancreatic Cysts: A Frequent Finding in Liver-Transplanted Patients as Assessed by 3D T2-Weighted Turbo Spin Echo Magnetic Resonance Cholangiopancreatography.</title><summary type='text'> JOP. 2009; 10(5): 507-514Girometti R, Intini SG, Cereser L, Bazzocchi M, Como G, Del Pin M, Baccarani U, Toniutto P, Zuiani CCONTEXT: The increasing frequency of incidental pancreatic cysts at imaging is a challenging topic due to the uncertainty of the aggressiveness of these lesions, especially small ones. To date, no data exist about their prevalence in a population of liver-transplanted </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8461153957257132095'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8461153957257132095'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/incidental-pancreatic-cysts-frequent.html' title='Incidental Pancreatic Cysts: A Frequent Finding in Liver-Transplanted Patients as Assessed by 3D T2-Weighted Turbo Spin Echo Magnetic Resonance Cholangiopancreatography.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2358457485067786966</id><published>2009-09-09T02:40:00.001-07:00</published><updated>2009-09-09T02:40:22.622-07:00</updated><title type='text'>Clinical phenotype of cystic fibrosis patients with the G551D mutation.</title><summary type='text'> QJM. 2009 Sep 4; Comer DM, Ennis M, McDowell C, Beattie D, Rendall J, Hall V, Elborn JSBACKGROUND: Data on whether the phenotype of cystic fibrosis (CF) patients with compound heterozygocity for G551D (Gly551Asp) differs from patients with F508del (Phe508del) homozygous mutations is divergent. AIM: We hypothesized that CF patients with the G551D mutation would have less severe disease than </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2358457485067786966'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2358457485067786966'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/clinical-phenotype-of-cystic-fibrosis.html' title='Clinical phenotype of cystic fibrosis patients with the G551D mutation.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2437508129236311351</id><published>2009-09-08T17:28:00.000-07:00</published><updated>2009-09-08T17:27:58.275-07:00</updated><title type='text'>Shielding, a new pathogen defense mechanism against polymorphonuclear neutrophilic leukocytes (PMNs).</title><summary type='text'> Microbiology. 2009 Sep 3; Cornelis PIn an article published in this issue, Alhede et al. demonstrate that the opportunistic pathogen Pseudomonas aeruginosa can react to the presence of PMNs by producing abundant quantities of rhamnose-containing glycolipid biosurfactants, the rhamnolipids. PMNs are phagocytic cells and are important players in the innate immune response since they produce a </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2437508129236311351'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2437508129236311351'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/shielding-new-pathogen-defense.html' title='Shielding, a new pathogen defense mechanism against polymorphonuclear neutrophilic leukocytes (PMNs).'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8099633899190808365</id><published>2009-09-05T16:28:00.000-07:00</published><updated>2009-09-05T16:27:59.945-07:00</updated><title type='text'>Prevalence of intestinal parasites in pet dogs in the United States.</title><summary type='text'> Vet Parasitol. 2009 Aug 5; Little SE, Johnson EM, Lewis D, Jaklitsch RP, Payton ME, Blagburn BL, Bowman DD, Moroff S, Tams T, Rich L, Aucoin DTo determine the national, regional, and age-related prevalence of intestinal parasites in dogs presenting to veterinarians in the United States, we reviewed the results of examination via zinc sulfate centrifugal flotation of 1,199,293 canine fecal </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8099633899190808365'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8099633899190808365'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/prevalence-of-intestinal-parasites-in.html' title='Prevalence of intestinal parasites in pet dogs in the United States.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1613902340871090723</id><published>2009-09-02T08:07:00.001-07:00</published><updated>2009-09-02T08:07:54.706-07:00</updated><title type='text'>Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT?</title><summary type='text'> Am J Surg Pathol. 2009 Sep; 33(9): 1314-21Mosquera JM, Fletcher CDDedifferentiation is a well recognized, if sometimes controversial, form of tumor progression in certain types of soft tissue and bone sarcoma, and confers a worse prognosis when compared with the low-grade counterpart. To date, dedifferentiation has not been described in solitary fibrous tumor (SFT). Among 948 cases of both </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1613902340871090723'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1613902340871090723'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/09/expanding-spectrum-of-malignant.html' title='Expanding the spectrum of malignant progression in solitary fibrous tumors: a study of 8 cases with a discrete anaplastic component--is this dedifferentiated SFT?'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-124092012658638677</id><published>2009-08-31T18:42:00.001-07:00</published><updated>2009-08-31T18:42:52.570-07:00</updated><title type='text'>Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis Mice.</title><summary type='text'> PLoS Genet. 2009 Jul; 5(7): e1000586Divangahi M, Balghi H, Danialou G, Comtois AS, Demoule A, Ernest S, Haston C, Robert R, Hanrahan JW, Radzioch D, Petrof BJCystic fibrosis (CF) patients often have reduced mass and strength of skeletal muscles, including the diaphragm, the primary muscle of respiration. Here we show that lack of the CF transmembrane conductance regulator (CFTR) plays an </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/124092012658638677'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/124092012658638677'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/lack-of-cftr-in-skeletal-muscle.html' title='Lack of CFTR in Skeletal Muscle Predisposes to Muscle Wasting and Diaphragm Muscle Pump Failure in Cystic Fibrosis Mice.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7484105512509026370</id><published>2009-08-30T15:51:00.001-07:00</published><updated>2009-08-30T15:51:01.816-07:00</updated><title type='text'>Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived GM-CSF and IL-1{beta}</title><summary type='text'> J Pharmacol Exp Ther. 2009 Jul 24; Bosnar M, Bosnjak B, Euziae S, Hrvaeiae B, Marjanoviae N, Glojnariae I, Euliae O, Parnham MJ, Erakoviae Haber VMacrolide antibiotics possess immunomodulatory / anti-inflammatory properties. These properties are considered fundamental for the efficacy of macrolide antibiotics in the treatment of chronic inflammatory diseases like diffuse panbronchiolitis and </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7484105512509026370'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7484105512509026370'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/azithromycin-and-clarithromycin-inhibit.html' title='Azithromycin and clarithromycin inhibit lipopolysaccharide-induced murine pulmonary neutrophilia mainly through effects on macrophage-derived GM-CSF and IL-1{beta}'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6855728704300817617</id><published>2009-08-30T08:09:00.001-07:00</published><updated>2009-08-30T08:09:51.838-07:00</updated><title type='text'>Improving genetic health care: A Northern New England pilot project addressing the genetic evaluation of the child with developmental delays or intellectual disability.</title><summary type='text'> Am J Med Genet C Semin Med Genet. 2009 Jul 20; Moeschler JB, Amato RS, Brewster T, Burke L, Dinulos MB, Smith R, Smith W, Miller PIn 2006, all clinical genetics practices in Northern New England (Vermont, New Hampshire, and Maine) formed a learning collaborative with the purpose of improving genetic health care and outcomes. This article describes the current status of this effort. The </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6855728704300817617'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6855728704300817617'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/improving-genetic-health-care-northern.html' title='Improving genetic health care: A Northern New England pilot project addressing the genetic evaluation of the child with developmental delays or intellectual disability.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1893519026595309197</id><published>2009-08-30T03:52:00.001-07:00</published><updated>2009-08-30T03:52:48.779-07:00</updated><title type='text'>Morphological and molecular phylogenetic analysis of two Saprolegnia sp. (Oomycetes) isolated from silver crucian carp and zebra fish.</title><summary type='text'> Mycol Res. 2009 Feb 6; Ke XL, Wang JG, Gu ZM, Li M, Gong XNTwo Saprolegnia isolates, JY isolated from silver crucian carp (Carassius auratus gibelio Bloch) and BMY isolated from zebra fish (Brachydanio rerio Hamilton) came from infections occurring concurrently in different locations in China. To confirm whether the two isolates were from the same Saprolegnia clone, comparative studies have been</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1893519026595309197'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1893519026595309197'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/morphological-and-molecular.html' title='Morphological and molecular phylogenetic analysis of two Saprolegnia sp. (Oomycetes) isolated from silver crucian carp and zebra fish.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1670301366529116030</id><published>2009-08-28T22:17:00.001-07:00</published><updated>2009-08-28T22:17:43.711-07:00</updated><title type='text'>Noncontact in vivo scanning laser microscopy of filtering blebs.</title><summary type='text'> J Glaucoma. 2009 Aug; 18(6): 479-83Sbeity Z, Palmiero PM, Tello C, Liebmann JM, Ritch RPURPOSE: To evaluate the ability of a noncontact, prototype scanning laser confocal microscope to image microstructural features of filtering blebs in vivo and to correlate these with the clinical features. METHODS: Thirty-one blebs of 24 patients underwent noncontact in vivo confocal microscopy using the </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1670301366529116030'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1670301366529116030'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/noncontact-in-vivo-scanning-laser.html' title='Noncontact in vivo scanning laser microscopy of filtering blebs.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8552605531719162921</id><published>2009-08-28T16:19:00.001-07:00</published><updated>2009-08-28T16:19:38.405-07:00</updated><title type='text'>Characteristics of Cl- uptake in rat alveolar type I cells.</title><summary type='text'> Am J Physiol Lung Cell Mol Physiol. 2009 Aug 14; Johnson M, Allen L, Dobbs LGAlthough Cl(-) transport in fetal lung is important for fluid secretion and normal lung development, the role of Cl(-) transport in adult lung is not well understood. In physiologic studies, the cystic fibrosis transmembrane regulator CFTR plays a role in fluid absorption in the distal airspaces of adult lung and </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8552605531719162921'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8552605531719162921'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/characteristics-of-cl-uptake-in-rat.html' title='Characteristics of Cl- uptake in rat alveolar type I cells.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-954053963741433546</id><published>2009-08-27T16:00:00.001-07:00</published><updated>2009-08-27T16:00:35.317-07:00</updated><title type='text'>Isocitrate lyase supplies precursors for hydrogen cyanide production in a cystic fibrosis isolate of Pseudomonas aeruginosa.</title><summary type='text'> J Bacteriol. 2009 Aug 21; Hagins JM, Locy R, Silo-Suh LPseudomonas aeruginosa colonizes and can persist in the lungs of cystic fibrosis (CF) patients for decades. Adaptation of P. aeruginosa to the CF lung environment causes various genotypic and phenotypic alterations in the bacterium that facilitate persistence. We showed previously that isocitrate lyase (ICL) activity is constitutively </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/954053963741433546'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/954053963741433546'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/isocitrate-lyase-supplies-precursors.html' title='Isocitrate lyase supplies precursors for hydrogen cyanide production in a cystic fibrosis isolate of Pseudomonas aeruginosa.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-4499123854973353269</id><published>2009-08-27T02:35:00.001-07:00</published><updated>2009-08-27T02:35:12.603-07:00</updated><title type='text'>Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast.</title><summary type='text'> Am J Surg Pathol. 2009 Aug 20; Chen YY, Hwang ES, Roy R, Devries S, Anderson J, Wa C, Fitzgibbons PL, Jacobs TW, Macgrogan G, Peterse H, Vincent-Salomon A, Tokuyasu T, Schnitt SJ, Waldman FMThe clinical, pathologic, and molecular features of pleomorphic lobular carcinoma in situ (PLCIS) and the relationship of PLCIS to classic LCIS (CLCIS) are poorly defined. In this study, we analyzed 31 cases </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4499123854973353269'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4499123854973353269'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/genetic-and-phenotypic-characteristics.html' title='Genetic and Phenotypic Characteristics of Pleomorphic Lobular Carcinoma In Situ of the Breast.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3448109227897173411</id><published>2009-08-26T16:11:00.001-07:00</published><updated>2009-08-26T16:11:14.279-07:00</updated><title type='text'>Immunology of whales and dolphins.</title><summary type='text'> Vet Immunol Immunopathol. 2009 Aug 3; Beineke A, Siebert U, Wohlsein P, BaumgÃ¤rtner WThe increasing disease susceptibility in different whale and dolphin populations has led to speculation about a possible negative influence of environmental contaminants on the immune system and therefore on the health status of marine mammals. Despite current efforts in the immunology of marine mammals several</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3448109227897173411'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3448109227897173411'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/immunology-of-whales-and-dolphins.html' title='Immunology of whales and dolphins.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-4185243485918422746</id><published>2009-08-25T15:50:00.001-07:00</published><updated>2009-08-25T15:50:14.601-07:00</updated><title type='text'>Oral contraceptives for functional ovarian cysts.</title><summary type='text'> Obstet Gynecol. 2009 Sep; 114(3): 679-80BACKGROUND:: Functional ovarian cysts are a common gynecological problem among women of reproductive age worldwide. When large, persistent, or painful, these cysts may require operations, sometimes resulting in removal of the ovary. Since early oral contraceptives were associated with a reduced incidence of functional ovarian cysts, many clinicians </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4185243485918422746'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4185243485918422746'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/oral-contraceptives-for-functional.html' title='Oral contraceptives for functional ovarian cysts.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2064703647567799758</id><published>2009-08-25T02:25:00.001-07:00</published><updated>2009-08-25T02:25:15.166-07:00</updated><title type='text'>Choledochal Cysts in Children and Adults with Contrasting Profiles: 11-Year Experience at a Tertiary Care Center in Kashmir.</title><summary type='text'> World J Surg. 2009 Aug 22; Shah OJ, Shera AH, Zargar SA, Shah P, Robbani I, Dhar S, Khan ABBACKGROUND: Choledochal cyst is a surgical problem usually related to infancy and childhood. Despite advancements in management, a large number of cases still present during adulthood. The clinical course and outcome in children varies from that in adults. This study focuses on these variations in terms of</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2064703647567799758'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2064703647567799758'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/choledochal-cysts-in-children-and.html' title='Choledochal Cysts in Children and Adults with Contrasting Profiles: 11-Year Experience at a Tertiary Care Center in Kashmir.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1281185674565621581</id><published>2009-08-24T23:01:00.001-07:00</published><updated>2009-08-24T23:01:18.740-07:00</updated><title type='text'>Update on new pulmonary therapies.</title><summary type='text'> Curr Opin Pulm Med. 2009 Aug 19; Retsch-Bogart GZPURPOSE OF REVIEW: Understanding the molecular and cellular processes responsible for the development of lung disease in cystic fibrosis (CF) has led to evaluation of a broad range of new therapies within multiple therapeutic classes. For these reasons, clinical research in CF is accelerating, as new agents progress through the early stages of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1281185674565621581'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1281185674565621581'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/update-on-new-pulmonary-therapies.html' title='Update on new pulmonary therapies.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2909457351908725567</id><published>2009-08-24T16:14:00.001-07:00</published><updated>2009-08-24T16:14:06.022-07:00</updated><title type='text'>Female boxing in Italy: 2002-2007 report.</title><summary type='text'> Br J Sports Med. 2009 Aug 19; Bianco M, Sanna N, Bucari S, Fabiano C, Palmieri V, Zeppilli POBJECTIVE: to collect medical data on women's boxing. DESIGN: Cross-sectional and longitudinal study. SETTING: Medical examinations requested by Italian laws. PARTICIPANTS: A retrospective study was conducted on all female boxing competitions in Italy from April 2001 to December 2007. Sixty-one amateur </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2909457351908725567'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2909457351908725567'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/female-boxing-in-italy-2002-2007-report.html' title='Female boxing in Italy: 2002-2007 report.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1910274163201612478</id><published>2009-08-24T08:20:00.001-07:00</published><updated>2009-08-24T08:20:48.792-07:00</updated><title type='text'>18-Fluorodeoxyglucose-PET/CT Imaging of Lungs in Patients With Cystic Fibrosis.</title><summary type='text'> Chest. 2009 Aug 20; Klein M, Cohen-Cymberknoh M, Armoni S, Shoseyov D, Chisin R, Orevi M, Freedman N, Kerem EBACKGROUND: Airway inflammation plays a critical role in the progression of cystic fibrosis (CF) lung disease and in the destruction of airways and lung parenchyma. Current methods to assess CF lung disease, (BAL, spirometry, HRCT), do not always accurately reflect actual disease states. </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1910274163201612478'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1910274163201612478'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/18-fluorodeoxyglucose-petct-imaging-of.html' title='18-Fluorodeoxyglucose-PET/CT Imaging of Lungs in Patients With Cystic Fibrosis.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8475914939052394937</id><published>2009-08-23T23:29:00.001-07:00</published><updated>2009-08-23T23:29:27.180-07:00</updated><title type='text'>Health Related Quality of Life of a Tertiary Referral Center Population With Urinary Incontinence Using the DCGM-10 Questionnaire.</title><summary type='text'> J Urol. 2009 Aug 18; Bachmann C, Lehr D, Janhsen E, Sambach H, Muehlan H, Gontard AV, Bachmann HPURPOSE: We evaluated health related quality of life of pediatric patients with nonneurogenic urinary incontinence and determined potential influencing factors. Also, health related quality of life results in our sample were compared to those of other chronic childhood health conditions. MATERIALS AND</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8475914939052394937'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8475914939052394937'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/health-related-quality-of-life-of.html' title='Health Related Quality of Life of a Tertiary Referral Center Population With Urinary Incontinence Using the DCGM-10 Questionnaire.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6871640456937170507</id><published>2009-08-23T07:23:00.001-07:00</published><updated>2009-08-23T07:23:46.003-07:00</updated><title type='text'>The association of host age and gender with inflammation around neurocysticercosis cysts.</title><summary type='text'> Ann Trop Med Parasitol. 2009 Sep; 103(6): 487-99Kelvin EA, Carpio A, Bagiella E, Leslie D, Leon P, Andrews H, Hauser WA,  The results of previous investigations indicate that age and gender may influence the strength of the human host's immune response to infection of the central nervous system with the larvae of Taenia solium. Most of the relevant research on such neurocysticercosis (NCC) has, </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6871640456937170507'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6871640456937170507'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/association-of-host-age-and-gender-with.html' title='The association of host age and gender with inflammation around neurocysticercosis cysts.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6497058674632598924</id><published>2009-08-23T00:17:00.001-07:00</published><updated>2009-08-23T00:17:48.187-07:00</updated><title type='text'>Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts.</title><summary type='text'> AJR Am J Roentgenol. 2009 Sep; 193(3): 722-31Sainani NI, Saokar A, Deshpande V, FernÃ¡ndez-del Castillo C, Hahn P, Sahani DVOBJECTIVE: The objective of our study was to compare MDCT with MRI-MR cholangiopancreatography (MRCP) in characterizing small pancreatic cysts (&lt; or = 3 cm) and predicting aggressiveness. MATERIALS AND METHODS: In a retrospective analysis, contrast-enhanced MDCT and MRI </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6497058674632598924'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6497058674632598924'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/comparative-performance-of-mdct-and-mri.html' title='Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2561232591984367669</id><published>2009-08-22T21:30:00.001-07:00</published><updated>2009-08-22T21:30:35.945-07:00</updated><title type='text'>Magnetic resonance imaging analysis of the bioabsorbable Milagro interference screw for graft fixation in anterior cruciate ligament reconstruction.</title><summary type='text'> Strategies Trauma Limb Reconstr. 2009 Aug 21; Frosch KH, Sawallich T, SchÃ¼tze G, Losch A, Walde T, Balcarek P, Konietschke F, StÃ¼rmer KMLigament graft fixation with bioabsorbable interference screws is a standard procedure in cruciate ligament replacement. Previous screw designs may resorb incompletely, and can cause osteolysis and sterile cysts despite being implanted for several years. The </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2561232591984367669'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2561232591984367669'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/magnetic-resonance-imaging-analysis-of.html' title='Magnetic resonance imaging analysis of the bioabsorbable Milagro interference screw for graft fixation in anterior cruciate ligament reconstruction.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3692081233653682460</id><published>2009-08-22T17:49:00.001-07:00</published><updated>2009-08-22T17:49:11.911-07:00</updated><title type='text'>Laparoscopic-assisted transgastric cholecystectomy and secure endoscopic closure of the transgastric defect in a survival porcine model.</title><summary type='text'> Endoscopy. 2009 Aug 14; Arezzo A, Kratt T, Schurr MO, Morino MBACKGROUND AND STUDY AIMS: Natural orifice transluminal endoscopic surgery holds promise for surgical interventions. Before the feasibility of this technique can be established, however, secure sealing of the transluminal access needs to be thoroughly investigated. PATIENTS AND METHODS: Following antibiotic prophylaxis and gastric </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3692081233653682460'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3692081233653682460'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/laparoscopic-assisted-transgastric.html' title='Laparoscopic-assisted transgastric cholecystectomy and secure endoscopic closure of the transgastric defect in a survival porcine model.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5716990121035316143</id><published>2009-08-21T18:53:00.001-07:00</published><updated>2009-08-21T18:53:09.776-07:00</updated><title type='text'>Staphylococcus aureus Nasal Colonization Among Pediatric CF Patients and Their Household Contacts.</title><summary type='text'> Pediatr Infect Dis J. 2009 Aug 14; Stone A, Quittell L, Zhou J, Alba L, Bhat M, Decelie-Germana J, Rajan S, Bonitz L, Welter JJ, Dozor AJ, Gherson I, Lowy FD, Saiman LBACKGROUND:: Little is known about the prevalence of Staphylococcus aureus nasal colonization and the epidemiology of methicillin-susceptible and methicillin-resistant S. aureus (MRSA) among cystic fibrosis (CF) patients and their </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5716990121035316143'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5716990121035316143'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/staphylococcus-aureus-nasal.html' title='Staphylococcus aureus Nasal Colonization Among Pediatric CF Patients and Their Household Contacts.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1394248828938826395</id><published>2009-08-20T20:54:00.001-07:00</published><updated>2009-08-20T20:54:51.600-07:00</updated><title type='text'>Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses.</title><summary type='text'> Ultrasound Obstet Gynecol. 2009 Aug 17; Sokalska A, Timmerman D, Testa AC, Van Holsbeke C, Lissoni AA, Leone FP, Jurkovic D, Valentin LOBJECTIVES: To determine the sensitivity and specificity of subjective evaluation of gray-scale and Doppler ultrasound findings (here called pattern recognition) when used by experienced ultrasound examiners with regard to making a specific diagnosis of adnexal </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1394248828938826395'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1394248828938826395'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/diagnostic-accuracy-of-transvaginal.html' title='Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5483848073839771974</id><published>2009-08-20T17:48:00.000-07:00</published><updated>2009-08-20T17:47:58.378-07:00</updated><title type='text'>A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Dia</title><summary type='text'> Ann Surg. 2009 Aug 14; Kauhanen SP, Komar G, SeppÃ¤nen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JTOBJECTIVE:: To prospectively compare the accuracy of combined positron emission tomography/computed tomography using F-fluorodeoxyglucose (FDG-PET/CT), multidetector row computed tomography (MDCT), and magnetic resonance imaging (MRI) </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5483848073839771974'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5483848073839771974'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/prospective-diagnostic-accuracy-study.html' title='A Prospective Diagnostic Accuracy Study of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography, Multidetector Row Computed Tomography, and Magnetic Resonance Imaging in Primary Dia'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1195682802118815955</id><published>2009-08-20T07:42:00.001-07:00</published><updated>2009-08-20T07:42:44.800-07:00</updated><title type='text'>Contralateral coronoid hyperplasia in patients undergoing hemimandibulectomy with disarticulation: a case series.</title><summary type='text'> J Oral Maxillofac Surg. 2009 Sep; 67(9): 1821-5Jamal BT, Taub D, Gold LPURPOSE: The purpose of this article is to evaluate whether hemimandibulectomy with disarticulation predisposes the patient to the development of contralateral coronoid hyperplasia, thereby justifying a coronoidectomy procedure for these patients to improve jaw function and mouth opening and decrease the length of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1195682802118815955'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1195682802118815955'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/contralateral-coronoid-hyperplasia-in.html' title='Contralateral coronoid hyperplasia in patients undergoing hemimandibulectomy with disarticulation: a case series.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2795833051399061486</id><published>2009-08-20T00:05:00.001-07:00</published><updated>2009-08-20T00:05:33.606-07:00</updated><title type='text'>Characterization of the ovarian and reproductive abnormalities in prepubertal and adult estrogen non-responsive estrogen receptor alpha knock-in (ENERKI) mice.</title><summary type='text'> Steroids. 2009 Jul 22; Sinkevicius KW, Woloszyn K, Laine M, Jackson KS, Greene GL, Woodruff TK, Burdette JEEstrogen non-responsive estrogen receptor alpha (ERalpha) knock-in (ENERKI) mice have a mutation (glycine 525 to leucine, G525L) in the ligand-binding domain of ERalpha. The mutant ERalpha protein has a significantly lower affinity and response to endogenous estrogens, while not altering </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2795833051399061486'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2795833051399061486'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/characterization-of-ovarian-and.html' title='Characterization of the ovarian and reproductive abnormalities in prepubertal and adult estrogen non-responsive estrogen receptor alpha knock-in (ENERKI) mice.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2605532865896540830</id><published>2009-08-19T21:59:00.001-07:00</published><updated>2009-08-19T21:59:22.203-07:00</updated><title type='text'>Differential expression of collagen type V and XI alpha-1 in human ascending thoracic aortic aneurysms.</title><summary type='text'> Ann Thorac Surg. 2009 Aug; 88(2): 506-13Toumpoulis IK, Oxford JT, Cowan DB, Anagnostopoulos CE, Rokkas CK, Chamogeorgakis TP, Angouras DC, Shemin RJ, Navab M, Ericsson M, Federman M, Levitsky S, McCully JDBACKGROUND: The molecular mechanisms leading to ascending thoracic aortic aneurysms (ATAAs) remain unknown. We hypothesized that alterations in expression levels of specific fibrillar collagens</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2605532865896540830'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2605532865896540830'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/differential-expression-of-collagen.html' title='Differential expression of collagen type V and XI alpha-1 in human ascending thoracic aortic aneurysms.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1439358967528666754</id><published>2009-08-19T17:34:00.001-07:00</published><updated>2009-08-19T17:34:24.359-07:00</updated><title type='text'>Methylation frequencies of cell-cycle associated genes in epithelial odontogenic tumours.</title><summary type='text'> Arch Oral Biol. 2009 Aug 11; Moreira PR, GuimarÃ£es MM, Gomes CC, Diniz MG, Brito JA, Castro WH, Gomez RSOBJECTIVE: The benign epithelial odontogenic tumours constitute a group of lesions derived from epithelial elements of the tooth-forming apparatus. This group includes lesions of different biological behaviour, such as ameloblastoma, calcifying cystic odontogenic tumour (CCOT) and adenomatoid</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1439358967528666754'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1439358967528666754'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/methylation-frequencies-of-cell-cycle.html' title='Methylation frequencies of cell-cycle associated genes in epithelial odontogenic tumours.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5701898072502320364</id><published>2009-08-19T00:29:00.001-07:00</published><updated>2009-08-19T00:29:37.858-07:00</updated><title type='text'>Receptor tyrosine phosphatases control tracheal tube geometries through negative regulation of Egfr signaling.</title><summary type='text'> Development. 2009 Aug 12; Jeon M, Zinn KThe formation of epithelial tubes with defined shapes and sizes is essential for organ development. We describe a unique tracheal tubulogenesis phenotype caused by loss of both Drosophila type III receptor tyrosine phosphatases (RPTPs), Ptp4E and Ptp10D. Ptp4E is the only widely expressed Drosophila RPTP, and is the last of the six fly RPTPs to be </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5701898072502320364'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5701898072502320364'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/receptor-tyrosine-phosphatases-control.html' title='Receptor tyrosine phosphatases control tracheal tube geometries through negative regulation of Egfr signaling.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7441070240801053378</id><published>2009-08-18T02:20:00.001-07:00</published><updated>2009-08-18T02:20:04.532-07:00</updated><title type='text'>Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.</title><summary type='text'> J Antimicrob Chemother. 2009 Aug 13; Macleod DL, Barker LM, Sutherland JL, Moss SC, Gurgel JL, Kenney TF, Burns JL, Baker WRObjectives To compare the in vitro and in vivo activities of a 4:1 (w/w) fosfomycin/tobramycin combination (FTI) with those of fosfomycin and tobramycin alone against cystic fibrosis (CF) and non-CF bronchiectasis pathogens. Methods Clinical isolates of CF Pseudomonas </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7441070240801053378'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7441070240801053378'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/antibacterial-activities-of.html' title='Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6083383320317429778</id><published>2009-08-17T23:25:00.001-07:00</published><updated>2009-08-17T23:25:52.893-07:00</updated><title type='text'>Conditional Deletion of Dnaic1 in a Murine Model of Primary Ciliary Dyskinesia Causes Chronic Rhinosinusitis.</title><summary type='text'> Am J Respir Cell Mol Biol. 2009 Aug 12; Ostrowski LE, Yin W, Rogers TD, Busalacchi KB, Chua M, O'Neal WK, Grubb BRStudies of Primary Ciliary Dyskinesia (PCD) have been hampered by the lack of a suitable animal model because disruption of essential ciliary genes in mice results in a high incidence of lethal hydrocephalus. To develop a viable mouse model for long-term studies of PCD, we have </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6083383320317429778'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6083383320317429778'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/conditional-deletion-of-dnaic1-in.html' title='Conditional Deletion of Dnaic1 in a Murine Model of Primary Ciliary Dyskinesia Causes Chronic Rhinosinusitis.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-4123011555842453895</id><published>2009-08-17T05:50:00.001-07:00</published><updated>2009-08-17T05:50:31.639-07:00</updated><title type='text'>Significance of cytomorphological and microbiological examination of bile collected by endoscopic cannulation of the papilla of vater.</title><summary type='text'> Indian J Pathol Microbiol. 2009 Jul-Sep; 52(3): 328-31Misra V, Misra SP, Singh PA, Dwivedi M, Verma K, Narayan UBACKGROUND: Bile analysis yields important information such as "biliary microlithiasis" and biliary tract colonization by microorganisms like Salmonella typhi or paratyphi, Escherichia coli, etc., which may progresses to cholelithiasis and have been found to have a role in the </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4123011555842453895'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4123011555842453895'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/significance-of-cytomorphological-and.html' title='Significance of cytomorphological and microbiological examination of bile collected by endoscopic cannulation of the papilla of vater.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8559411297696671654</id><published>2009-08-16T22:58:00.001-07:00</published><updated>2009-08-16T22:58:04.301-07:00</updated><title type='text'>Noncardiac pathology on clinical cardiac magnetic resonance imaging.</title><summary type='text'> JACC Cardiovasc Imaging. 2009 Aug; 2(8): 980-6Chan PG, Smith MP, Hauser TH, Yeon SB, Appelbaum E, Rofsky NM, Manning WJOBJECTIVES: We sought to determine the prevalence of noncardiac pathology in a large consecutive series of patients referred for clinical cardiac magnetic resonance (CMR) studies. BACKGROUND: The imaging field for many CMR sequences extends outside of the heart border. As a </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8559411297696671654'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8559411297696671654'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/noncardiac-pathology-on-clinical.html' title='Noncardiac pathology on clinical cardiac magnetic resonance imaging.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3863839230862300759</id><published>2009-08-15T22:56:00.001-07:00</published><updated>2009-08-15T22:56:43.265-07:00</updated><title type='text'>Benign bone cyst mimicking skeletal metastasis on (18)F-FDG-PET.</title><summary type='text'> Hell J Nucl Med. 2009 May-Aug; 12(2): 179-80Khurana A, Jaimini A, Tripathi M, Mondal ATo the Editor: We read with interest in Hell J Nucl Med the letter by Seven B. et al. on: "Aneurysmal bone cyst of the second metatarsal: three-phase bone scan findings and radiological assessment" published in 2008; 11(3): 189-190. We now report another case of "active/viable" bone cyst shown in the fluorine-</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3863839230862300759'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3863839230862300759'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/benign-bone-cyst-mimicking-skeletal.html' title='Benign bone cyst mimicking skeletal metastasis on (18)F-FDG-PET.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6912110253534805984</id><published>2009-08-13T17:36:00.001-07:00</published><updated>2009-08-13T17:36:11.458-07:00</updated><title type='text'>Adenoid Cystic Carcinoma-Like Pattern in Spiradenoma and Spiradenocylindroma: A Rare Feature in Sporadic Neoplasms and Those Associated With Brooke-Spiegler Syndrome.</title><summary type='text'> Am J Dermatopathol. 2009 Jul 23; Petersson F, Kutzner H, Spagnolo DV, Bisceglia M, Kacerovska D, Vazmitel M, Michal M, Kazakov DVSpiradenoma is a benign, morphologically well-defined cutaneous adnexal neoplasm that is closely related to cylindroma. We present the rare occurrence of adenoid cystic carcinoma (ACC)-like areas in 7 spiradenomas and 1 spiradenocylindroma, not described in the English</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6912110253534805984'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6912110253534805984'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/adenoid-cystic-carcinoma-like-pattern.html' title='Adenoid Cystic Carcinoma-Like Pattern in Spiradenoma and Spiradenocylindroma: A Rare Feature in Sporadic Neoplasms and Those Associated With Brooke-Spiegler Syndrome.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2732102278540779019</id><published>2009-08-12T17:35:00.001-07:00</published><updated>2009-08-12T17:35:28.769-07:00</updated><title type='text'>Laparoscopic Decortication of Large Renal Cysts: A Comparison Between the Transperitoneal and Retroperitoneal Approaches.</title><summary type='text'> J Laparoendosc Adv Surg Tech A. 2009 Aug 1; Ryu DS, Oh THAbstract Background: We compared the operative outcomes and follow-up results of laparoscopic decortication of large, simple renal cysts, performed by the transperitoneal (TP) and retroperitoneal (RP) approaches, and identified selection criteria for each approach. Materials and Methods: Between 2000 and 2007, 53 patients with renal cysts </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2732102278540779019'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2732102278540779019'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/laparoscopic-decortication-of-large.html' title='Laparoscopic Decortication of Large Renal Cysts: A Comparison Between the Transperitoneal and Retroperitoneal Approaches.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5267324998954187206</id><published>2009-08-12T06:37:00.001-07:00</published><updated>2009-08-12T06:37:37.227-07:00</updated><title type='text'>Radiographic size versus surgical size of renal masses: Which is the true size of the tumor?</title><summary type='text'> J BUON. 2009 Apr-Jun; 14(2): 235-8Alicioglu B, Kaplan M, Yurut-Caloglu V, Usta U, Levent SPurpose: The size of a renal neoplasm is important for staging, prognosis and selection of appropriate treatment. Our aim was to determine whether there is a discrepancy between the radiographic and pathological size of renal tumors. Patients and methods: The maximum size of 35 resected renal tumors was </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5267324998954187206'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5267324998954187206'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/radiographic-size-versus-surgical-size.html' title='Radiographic size versus surgical size of renal masses: Which is the true size of the tumor?'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-9180964844215723860</id><published>2009-08-11T18:39:00.001-07:00</published><updated>2009-08-11T18:39:45.687-07:00</updated><title type='text'>[Pathophysiology and immune response in sheep experimentally infected with Echinococcus granulosus.]</title><summary type='text'> Medicina (B Aires). 2009; 69(3): 341-6Larrieu E, Alvarez AR, Gatti A, Mancini S, Bigatti R, Araya D, Vespoli V, GarcÃ­a Vinet J, GarcÃ­a Cacheau M, Alvarez E, Cavagion LThe immune response to Echinococcus granulosus in sheep has not been extensively investigated. The objective of this study was to increase the information on the physiopathology of E. granulosus and the immune response elicited </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/9180964844215723860'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/9180964844215723860'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/pathophysiology-and-immune-response-in.html' title='[Pathophysiology and immune response in sheep experimentally infected with Echinococcus granulosus.]'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3456472584248655858</id><published>2009-08-11T07:22:00.001-07:00</published><updated>2009-08-11T07:22:29.384-07:00</updated><title type='text'>Endoscopic treatment of middle fossa arachnoid cysts: a series of 40 patients treated endoscopically in two centres.</title><summary type='text'> Childs Nerv Syst. 2009 Jul 24; Spacca B, Kandasamy J, Mallucci CL, Genitori LPURPOSE: Middle fossa arachnoid cysts (MFAC) are a relatively common, benign pathology that pose a therapeutic challenge for both symptomatic and asymptomatic patients. The optimal surgical strategy and indication to treat are still debated by neurosurgeons. We reviewed our experience and results in a group of patients </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3456472584248655858'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3456472584248655858'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/endoscopic-treatment-of-middle-fossa.html' title='Endoscopic treatment of middle fossa arachnoid cysts: a series of 40 patients treated endoscopically in two centres.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-986540659419134699</id><published>2009-08-11T02:03:00.001-07:00</published><updated>2009-08-11T02:03:45.373-07:00</updated><title type='text'>Provision of contraception services and advice for women with cystic fibrosis.</title><summary type='text'> J Fam Plann Reprod Health Care. 2009 Jul; 35(3): 157-60Gatiss S, Mansour D, Doe S, Bourke SBACKGROUND AND METHODOLOGY: As the prognosis of patients with cystic fibrosis (CF) improves, issues of sexual health, fertility, pregnancy and contraception are increasingly important. In order to plan the provision of a contraception and sexual health service for women with CF we studied their sexual and </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/986540659419134699'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/986540659419134699'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/provision-of-contraception-services-and.html' title='Provision of contraception services and advice for women with cystic fibrosis.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6403997216747540181</id><published>2009-08-10T23:17:00.001-07:00</published><updated>2009-08-10T23:17:12.927-07:00</updated><title type='text'>Pancreatic ductal adenocarcinoma with intratumoral cystic lesions on MRI: correlation with histopathological findings.</title><summary type='text'> Br J Radiol. 2009 Jul 20; Yoon SE, Byun JH, Kim KA, Kim HJ, Lee SS, Jang SJ, Jang YJ, Lee MGThe purpose of this study was to evaluate intratumoral cystic lesions of pancreatic ductal adenocarcinoma (PDAC) depicted on MRI, and to correlate these cystic lesions with their histopathological findings. This study included 12 patients (7 males and 5 females; mean age, 59 years) with intratumoral </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6403997216747540181'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6403997216747540181'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/pancreatic-ductal-adenocarcinoma-with.html' title='Pancreatic ductal adenocarcinoma with intratumoral cystic lesions on MRI: correlation with histopathological findings.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1416445591056052373</id><published>2009-08-10T07:36:00.001-07:00</published><updated>2009-08-10T07:36:52.538-07:00</updated><title type='text'>Supratentorial abnormalities in the Chiari II malformation, III: The interhemispheric cyst.</title><summary type='text'> J Ultrasound Med. 2009 Aug; 28(8): 999-1006Wong SK, Barkovich AJ, Callen AL, Filly RAOBJECTIVE: Our clinical observations noted an interhemispheric "cyst," a protrusion of the posterior superior third ventricle, in fetuses with myelomeningocele (MMC). The study analyzed the frequency of this observation and features that influence its visualization. METHODS: We searched for cases of fetal MMC </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1416445591056052373'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1416445591056052373'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/supratentorial-abnormalities-in-chiari.html' title='Supratentorial abnormalities in the Chiari II malformation, III: The interhemispheric cyst.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5841333381706979893</id><published>2009-08-09T23:19:00.001-07:00</published><updated>2009-08-09T23:19:20.456-07:00</updated><title type='text'>Airway Surface Liquid Contains Endogenous DNase Activity which Can be Activated by Exogenous Magnesium.</title><summary type='text'> Eur J Med Res. 2009 Jul 22; 14(7): 304-8Rosenecker J, Naundorf S, Rudolph CIntroduction: The removal of highly viscous mucus from the airways is an important task in the treatment of chronic lung disease like in cystic fibrosis. The inhalation of recombinant human DNase- I (rhDNase-I) is used to facilitate the removal of tenacious airway secretions in different lung diseases and especially in CF</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5841333381706979893'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5841333381706979893'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/airway-surface-liquid-contains.html' title='Airway Surface Liquid Contains Endogenous DNase Activity which Can be Activated by Exogenous Magnesium.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2336926150928957027</id><published>2009-08-09T17:25:00.000-07:00</published><updated>2009-08-09T17:24:59.265-07:00</updated><title type='text'>Asymptomatic congenital cystic adenomatoid malformation of the lung: Is it time to operate?</title><summary type='text'> J Thorac Cardiovasc Surg. 2009 Mar 25; Conforti A, Aloi I, Trucchi A, Morini F, Nahom A, Inserra A, Bagolan POBJECTIVE: The optimal management of congenital adenomatoid malformation of the lung remains controversial. Prenatal ultrasonographic analysis has increasingly discovered asymptomatic lesions, raising questions about the need for and timing of surgical treatment for asymptomatic </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2336926150928957027'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2336926150928957027'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/asymptomatic-congenital-cystic.html' title='Asymptomatic congenital cystic adenomatoid malformation of the lung: Is it time to operate?'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5406249308166355095</id><published>2009-08-09T15:41:00.001-07:00</published><updated>2009-08-09T15:41:57.480-07:00</updated><title type='text'>Caenorhabditis elegans Semi-Automated Liquid Screen Reveals a Specialized Role for the Chemotaxis Gene cheB2 in Pseudomonas aeruginosa Virulence.</title><summary type='text'> PLoS Pathog. 2009 Aug; 5(8): e1000540Garvis S, Munder A, Ball G, de Bentzmann S, Wiehlmann L, Ewbank JJ, TÃ¼mmler B, Filloux APseudomonas aeruginosa is an opportunistic human pathogen that causes infections in a variety of animal and plant hosts. Caenorhabditis elegans is a simple model with which one can identify bacterial virulence genes. Previous studies with C. elegans have shown that </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5406249308166355095'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5406249308166355095'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/caenorhabditis-elegans-semi-automated.html' title='Caenorhabditis elegans Semi-Automated Liquid Screen Reveals a Specialized Role for the Chemotaxis Gene cheB2 in Pseudomonas aeruginosa Virulence.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3990687498272989893</id><published>2009-08-09T07:19:00.001-07:00</published><updated>2009-08-09T07:19:32.619-07:00</updated><title type='text'>Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results.</title><summary type='text'> Hum Genet. 2009 Aug 7; Dorfman R, Li W, Sun L, Lin F, Wang Y, Sandford A, ParÃ© PD, McKay K, Kayserova H, Piskackova T, Macek M, Czerska K, Sands D, Tiddens H, Margarit S, Repetto G, Sontag MK, Accurso FJ, Blackman S, Cutting GR, Tsui LC, Corey M, Durie P, Zielenski J, Strug LJCystic fibrosis (CF) is a monogenic disease due to mutations in the CFTR gene. Yet, variability in CF disease </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3990687498272989893'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3990687498272989893'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/modifier-gene-study-of-meconium-ileus.html' title='Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7325071341051952000</id><published>2009-08-09T06:56:00.001-07:00</published><updated>2009-08-09T06:56:36.287-07:00</updated><title type='text'>Outcome and treatment in an antenatally diagnosed congenital cystic adenomatoid malformation of the lung.</title><summary type='text'> Pediatr Surg Int. 2009 Aug 7; Nagata K, Masumoto K, Tesiba R, Esumi G, Tsukimori K, Norio W, Taguchi TBACKGROUND: The natural history of patients with antenatally diagnosed congenital cystic adenomatoid malformation of the lung (CCAM) is still fully unknown. In symptomatic patients with respiratory distress, an operation is performed during the neonatal period. However, in asymptomatic patients,</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7325071341051952000'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7325071341051952000'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/outcome-and-treatment-in-antenatally.html' title='Outcome and treatment in an antenatally diagnosed congenital cystic adenomatoid malformation of the lung.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7253539457356695866</id><published>2009-08-08T01:04:00.001-07:00</published><updated>2009-08-08T01:04:07.531-07:00</updated><title type='text'>Laparoscopic Simultaneous Treatment of Peripelvic Renal Cysts and Stones: Case Series.</title><summary type='text'> J Endourol. 2009 Jul 20; Micali S, Pini G, Sighinolfi MC, De Stefani S, Annino F, Bianchi GAbstract Introduction: Renal multiple peripelvic cysts are often symptomatic. Obstruction of renal hilum and the collecting system leads to hydronephrosis and could promote formation of stones. Managing both entities at the same time needs a new approach to minimize complications and improve success rates.</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7253539457356695866'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7253539457356695866'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/laparoscopic-simultaneous-treatment-of.html' title='Laparoscopic Simultaneous Treatment of Peripelvic Renal Cysts and Stones: Case Series.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6397004698307556952</id><published>2009-08-07T16:13:00.001-07:00</published><updated>2009-08-07T16:13:18.494-07:00</updated><title type='text'>Adverse events arising from a palliative care survey.</title><summary type='text'> Palliat Med. 2009 Jul 31; Braithwaite M, Philip J, Finlayson F, Tranberg H, Gold M, Kotsimbos T, Wilson JDevelopment of evidence-based practice requires investigation of the attitudes and needs of patients, families and healthcare professionals, particularly for sensitive subject areas. Cystic fibrosis (CF) is a recessively inherited life-limiting disorder resulting in early death. Patients with</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6397004698307556952'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6397004698307556952'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/adverse-events-arising-from-palliative.html' title='Adverse events arising from a palliative care survey.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-4523915119520624230</id><published>2009-08-06T02:32:00.001-07:00</published><updated>2009-08-06T02:32:16.145-07:00</updated><title type='text'>Symptomatic intracystic hemorrhage in pineal cysts.</title><summary type='text'> J Neurosurg Pediatr. 2009 Aug; 4(2): 130-6Sarikaya-Seiwert S, Turowski B, HÃ¤nggi D, Janssen G, Steiger HJ, Stummer WPineal cysts are benign and often asymptomatic intracranial entities. Occasionally they can lead to neurological symptoms through growth or due to intracystic hemorrhage. The purpose of the current report is to describe their clinical characteristics and treatment options. In the </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4523915119520624230'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4523915119520624230'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/symptomatic-intracystic-hemorrhage-in.html' title='Symptomatic intracystic hemorrhage in pineal cysts.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3828732169134079128</id><published>2009-08-05T17:54:00.001-07:00</published><updated>2009-08-05T17:54:44.278-07:00</updated><title type='text'>Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management.</title><summary type='text'> Gastrointest Endosc. 2009 Jul 30; Das A, Ngamruengphong S, Nagendra S, Chak ABACKGROUND: Optimal management of asymptomatic pancreatic cystic neoplasm is not known. OBJECTIVE: In a decision analysis, the cost-effectiveness of different strategies for managing solitary, asymptomatic pancreatic cystic neoplasm were compared. INTERVENTION: Three strategies were examined in a Markov model with a </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3828732169134079128'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3828732169134079128'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/asymptomatic-pancreatic-cystic-neoplasm.html' title='Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8079912824373816900</id><published>2009-08-04T17:34:00.001-07:00</published><updated>2009-08-04T17:34:11.821-07:00</updated><title type='text'>Limitations of the Murine Nose in the Development of Non-viral Airway Gene Transfer.</title><summary type='text'> Am J Respir Cell Mol Biol. 2009 Jul 31; Griesenbach U, Sumner-Jones SG, Holder E, Munkonge FM, Wodehouse T, Smith SN, Wasowicz MY, Pringle I, Casamayor I, Chan M, Coles R, Cornish N, Dewar A, Doherty A, Farley R, Green AM, Jones BL, Larsen MD, Lawton AE, Manvell M, Painter H, Singh C, Somerton L, Stevenson B, Varathalingam A, Siegel C, Scheule RK, Cheng SH, Davies JC, Porteous DJ, Gill DR, Boyd </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8079912824373816900'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8079912824373816900'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/limitations-of-murine-nose-in.html' title='Limitations of the Murine Nose in the Development of Non-viral Airway Gene Transfer.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2164696098503358347</id><published>2009-08-04T04:49:00.001-07:00</published><updated>2009-08-04T04:49:47.818-07:00</updated><title type='text'>Adjuvant Chemoradiotherapy After Pancreatic Resection for Invasive Carcinoma Associated with Intraductal Papillary Mucinous Neoplasm of the Pancreas.</title><summary type='text'> Int J Radiat Oncol Biol Phys. 2009 Jul 31; Swartz MJ, Hsu CC, Pawlik TM, Winter J, Hruban RH, Guler M, Schulick RD, Cameron JL, Laheru DA, Wolfgang CL, Herman JMPURPOSE: Intraductal papillary mucinous neoplasms are mucin-producing cystic neoplasms of the pancreas. One-third are associated with invasive carcinoma. We examined the benefit of adjuvant chemoradiotherapy (CRT) for this cohort. </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2164696098503358347'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2164696098503358347'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/adjuvant-chemoradiotherapy-after.html' title='Adjuvant Chemoradiotherapy After Pancreatic Resection for Invasive Carcinoma Associated with Intraductal Papillary Mucinous Neoplasm of the Pancreas.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2924027491718581935</id><published>2009-08-04T03:12:00.001-07:00</published><updated>2009-08-04T03:12:03.467-07:00</updated><title type='text'>Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia.</title><summary type='text'> PLoS One. 2009; 4(7): e6454Cai KQ, Caslini C, Capo-chichi CD, Slater C, Smith ER, Wu H, Klein-Szanto AJ, Godwin AK, Xu XXBACKGROUND: The family of zinc finger-containing GATA transcription factors plays critical roles in cell lineage specification during early embryonic development and organ formation. GATA4 and GATA6 were found to be frequently lost in ovarian cancer, and the loss is proposed </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2924027491718581935'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2924027491718581935'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/loss-of-gata4-and-gata6-expression.html' title='Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-793218793539056155</id><published>2009-08-03T21:09:00.001-07:00</published><updated>2009-08-03T21:09:17.792-07:00</updated><title type='text'>[Report of the National Renal Ultrasound Study Group on the ultrasound activity of nephrology care units in Italy.]</title><summary type='text'> G Ital Nefrol. 2009 Jul-Aug; 26(4): 523-9Petrarulo F, Alberghini E, Capotondo L, Logias F, Melfa G, Mancini AThe presence of operational and organizational differences in the use of ultrasonography in Italian nephrology units has prompted this survey on a nationwide scale. The survey was carried out by questionnaire and included questions about the activity and equipment of each nephrology unit,</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/793218793539056155'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/793218793539056155'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/report-of-national-renal-ultrasound.html' title='[Report of the National Renal Ultrasound Study Group on the ultrasound activity of nephrology care units in Italy.]'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3075065495964643552</id><published>2009-08-03T20:44:00.001-07:00</published><updated>2009-08-03T20:44:10.055-07:00</updated><title type='text'>Percutaneous treatment of lymphatic malformations.</title><summary type='text'> Otolaryngol Head Neck Surg. 2009 Aug; 141(2): 219-224Shiels WE, Kang DR, Murakami JW, Hogan MJ, Wiet GJOBJECTIVE: The aim of this study is to investigate a new treatment regimen for macrocystic and microcystic lymphatic malformations (LM) of the head and neck. STUDY DESIGN: The study represents a retrospective review of outcomes from new percutaneous treatments for lymphatic malformations. </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3075065495964643552'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3075065495964643552'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/percutaneous-treatment-of-lymphatic.html' title='Percutaneous treatment of lymphatic malformations.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2827803598295737750</id><published>2009-08-03T18:04:00.001-07:00</published><updated>2009-08-03T18:04:41.051-07:00</updated><title type='text'>Adenosine receptors, cystic fibrosis, and airway hydration.</title><summary type='text'> Handb Exp Pharmacol. 2009; 363-81Com G, Clancy JPAdenosine (Ado) regulates diverse cellular functions in the lung through its local production, release, metabolism, and subsequent stimulation of G-protein-coupled P1 purinergic receptors. The A(2B) adenosine receptor (A(2B)AR) is the predominant P1 purinergic receptor isoform expressed in surface airway epithelia, and Ado is an important </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2827803598295737750'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2827803598295737750'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/adenosine-receptors-cystic-fibrosis-and.html' title='Adenosine receptors, cystic fibrosis, and airway hydration.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8100192128235137775</id><published>2009-08-03T01:23:00.001-07:00</published><updated>2009-08-03T01:23:20.473-07:00</updated><title type='text'>Diplopia and Fluoroquinolones.</title><summary type='text'> Ophthalmology. 2009 Jul 28; Fraunfelder FW, Fraunfelder FTPURPOSE: To report a possible association between fluoroquinolones and diplopia. DESIGN: Database study. PARTICIPANTS: A total of 171 subjects were studied. METHODS: Spontaneous reports from the National Registry of Drug-Induced Ocular Side Effects, World Health Organization, and Food and Drug Administration were collected on </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8100192128235137775'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8100192128235137775'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/diplopia-and-fluoroquinolones.html' title='Diplopia and Fluoroquinolones.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8225020208750762839</id><published>2009-08-02T17:43:00.001-07:00</published><updated>2009-08-02T17:43:36.550-07:00</updated><title type='text'>Synaptic scaffolding molecule binds to and regulates vasoactive intestinal polypeptide type-1 receptor in epithelial cells.</title><summary type='text'> Gastroenterology. 2009 Aug; 137(2): 607-17, 617.e1-4Gee HY, Kim YW, Jo MJ, Namkung W, Kim JY, Park HW, Kim KS, Kim H, Baba A, Yang J, Kim E, Kim KH, Lee MGBACKGROUND &amp; AIMS: Vasoactive intestinal polypeptide (VIP) is a principal regulator of fluid and electrolyte secretion in the gastrointestinal system. The VIP type-1 receptor (VPAC1), a class II G-protein-coupled receptor, contains a putative </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8225020208750762839'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8225020208750762839'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/synaptic-scaffolding-molecule-binds-to.html' title='Synaptic scaffolding molecule binds to and regulates vasoactive intestinal polypeptide type-1 receptor in epithelial cells.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7942566289028558383</id><published>2009-08-02T15:52:00.001-07:00</published><updated>2009-08-02T15:52:37.878-07:00</updated><title type='text'>The expression of the o-linked n-acetylglucosamine containing epitope H in the gemistocytic, pilocytic and subependymal giant cell astrocytomas.</title><summary type='text'> Oncol Rep. 2009 Sep; 22(3): 521-4Arvanitis LD, Koukoulis GK, Kanavaros PThe epitope H contains an O-linked N-acetylglucosamine residue in a specific conformation and/or environment recognized by the monoclonal antibody H. It has previously been shown that the epitope H is present in several types of normal and pathological cells and in several polypeptides. In normal human brains the epitope H </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7942566289028558383'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7942566289028558383'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/expression-of-o-linked-n.html' title='The expression of the o-linked n-acetylglucosamine containing epitope H in the gemistocytic, pilocytic and subependymal giant cell astrocytomas.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6468330609990641458</id><published>2009-08-02T07:29:00.001-07:00</published><updated>2009-08-02T07:29:31.794-07:00</updated><title type='text'>Diffusion-weighted Imaging Characteristics of Primary Central Nervous System Germinoma with Histopathologic Correlation A Retrospective Study(1).</title><summary type='text'> Acad Radiol. 2009 Jul 28; Douglas-Akinwande AC, Ying J, Momin Z, Mourad A, Hattab EMRATIONALE AND OBJECTIVES: The aim of this study was to quantify, using diffusion-weighted magnetic resonance imaging, the microscopic rate of water diffusion in pure germinoma and to determine whether or not the apparent diffusion coefficient (ADC) values correlated with the different histologic components. </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6468330609990641458'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6468330609990641458'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/diffusion-weighted-imaging.html' title='Diffusion-weighted Imaging Characteristics of Primary Central Nervous System Germinoma with Histopathologic Correlation A Retrospective Study(1).'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-693268127524205812</id><published>2009-08-02T06:26:00.001-07:00</published><updated>2009-08-02T06:26:47.917-07:00</updated><title type='text'>Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration.</title><summary type='text'> Ophthalmology. 2009 Jul 28; Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PKOBJECTIVE: To evaluate the visual outcomes for intravitreal ranibizumab administered on an as-needed basis for exudative age-related macular degeneration (AMD) and to investigate the relationship between injection frequency and visual outcome in this setting. DESIGN: Retrospective, interventional case series. </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/693268127524205812'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/693268127524205812'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/evaluation-of-injection-frequency-and.html' title='Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-4368141129935531549</id><published>2009-08-02T00:45:00.001-07:00</published><updated>2009-08-02T00:45:56.926-07:00</updated><title type='text'>Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis - Is it good for the patient?</title><summary type='text'> Ann Thorac Med. 2009 Jul; 4(3): 111-4Sequeiros IM, Jarad NAThere is a worldwide drive for the home management of chronic respiratory diseases. With the widespread use of home intravenous (IV) treatment for cystic fibrosis (CF) pulmonary exacerbations (PExs), evidence pointing to an inferior outcome of care for home-treated patients in comparison to hospital-treated patients is a cause of concern</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4368141129935531549'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4368141129935531549'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/08/home-intravenous-antibiotic-treatment.html' title='Home intravenous antibiotic treatment for acute pulmonary exacerbations in cystic fibrosis - Is it good for the patient?'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-3647186363735113249</id><published>2009-07-31T20:48:00.001-07:00</published><updated>2009-07-31T20:48:03.628-07:00</updated><title type='text'>Modelling the age variation of larval protoscoleces of Echinococcus granulosus in sheep.</title><summary type='text'> Int J Parasitol. 2009 Feb 4; Torgerson PR, Ziadinov I, Aknazarov D, Nurgaziev R, Deplazes PIn autumn 2006, a study of the age-dynamics of Echinoccus granulosus cyst abundance was undertaken from an abattoir study of 1,081 sheep slaughtered in Naryn Province in central Kyrgyzstan, an area endemic for echinococcosis. The results demonstrated approximately 64% of sheep were infected with the </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3647186363735113249'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/3647186363735113249'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/modelling-age-variation-of-larval.html' title='Modelling the age variation of larval protoscoleces of Echinococcus granulosus in sheep.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8764813697197856441</id><published>2009-07-31T17:53:00.001-07:00</published><updated>2009-07-31T17:53:11.698-07:00</updated><title type='text'>Effectiveness of a family-oriented rehabilitation program on the quality of life of parents of chronically ill children.</title><summary type='text'> Klin Padiatr. 2009 Jul-Aug; 221(4): 241-6West CA, Besier T, Borth-Bruhns T, Goldbeck LBACKGROUND: Parents of chronically ill children face numerous burdens in daily life, which can impair their quality of life (QoL) significantly. Therefore in family-oriented rehabilitation, not only the children themselves, but also their parents receive interventions. These aim at stabilizing parents both </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8764813697197856441'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8764813697197856441'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/effectiveness-of-family-oriented.html' title='Effectiveness of a family-oriented rehabilitation program on the quality of life of parents of chronically ill children.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8033344744072325451</id><published>2009-07-30T20:59:00.001-07:00</published><updated>2009-07-30T20:59:15.998-07:00</updated><title type='text'>Molecular and morphological characterisation of Echinococcus from food producing animals in India.</title><summary type='text'> Vet Parasitol. 2009 Jun 24; Pednekar RP, Gatne ML, Thompson RC, Traub RJIn view of the medical, veterinary and economic importance of hydatid disease in India, our study aimed to determine the prevalence and genotypes of Echinococcus present in domestic livestock in India. Out of 21,861 animals examined, cattle were found with the highest prevalence of hydatid cysts (5.10%) followed by buffaloes</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8033344744072325451'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8033344744072325451'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/molecular-and-morphological.html' title='Molecular and morphological characterisation of Echinococcus from food producing animals in India.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5286620829357788601</id><published>2009-07-30T17:27:00.001-07:00</published><updated>2009-07-30T17:27:08.672-07:00</updated><title type='text'>GCDFP-15 Positive and TTF-1 Negative Primary Lung Neoplasms: A Tissue Microarray Study of 381 Primary Lung Tumors.</title><summary type='text'> Appl Immunohistochem Mol Morphol. 2009 Jul 17; Wang LJ, Greaves WO, Sabo E, Noble L, Tavares R, Ng T, Delellis RA, Resnick MBGross cystic disease fluid protein (GCDFP-15) is currently used as an immunohistochemical marker of breast cancer, whereas thyroid transcription factor (TTF-1) is commonly used as a marker of primary lung neoplasms. Traditionally, a GCDFP-15+/TTF-1- immunohistochemical </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5286620829357788601'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5286620829357788601'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/gcdfp-15-positive-and-ttf-1-negative.html' title='GCDFP-15 Positive and TTF-1 Negative Primary Lung Neoplasms: A Tissue Microarray Study of 381 Primary Lung Tumors.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5725895349859413880</id><published>2009-07-30T06:22:00.000-07:00</published><updated>2009-07-30T06:39:10.037-07:00</updated><category scheme='http://www.blogger.com/atom/ns#' term='cystic fibrosis treatment'/><title type='text'>Future cystic fibrosis treatment, gene therapy</title><summary type='text'>Cystic fibrosis is a hereditary disease that affects one in every 2500 live births. It is the most common genetic disease of whites and one in 25 people carries the gene that causes the disease.Affected individuals have a reduced life expectancy, although in recent years has increased the average years to live.For a newborn child inheriting the disease, both parents must be carriers of the </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5725895349859413880'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5725895349859413880'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/future-cystic-fibrosis-treatment-gene.html' title='Future cystic fibrosis treatment, gene therapy'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5601768322731590841</id><published>2009-07-30T05:51:00.000-07:00</published><updated>2009-07-30T05:52:00.743-07:00</updated><title type='text'>Acid Sphingomyelinase Inhibitors Normalize Pulmonary Ceramide and Inflammation in Cystic Fibrosis.</title><summary type='text'> Am J Respir Cell Mol Biol. 2009 Jul 27; Becker KA, RiethmÃ¼ller J, LÃ¼th A, DÃ¶ring G, Kleuser B, Gulbins EBackground: Employing genetic mouse models we have recently shown that ceramide accumulation is critically involved in the pathogenesis of cystic fibrosis (CF) lung disease. Rationale: Genetic or systemic inhibition of the acid sphingomyelinase (Asm) is not feasible for treatment of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5601768322731590841'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5601768322731590841'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/acid-sphingomyelinase-inhibitors.html' title='Acid Sphingomyelinase Inhibitors Normalize Pulmonary Ceramide and Inflammation in Cystic Fibrosis.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-5935062113513840733</id><published>2009-07-30T02:38:00.001-07:00</published><updated>2009-07-30T02:38:12.153-07:00</updated><title type='text'>Genetic categorization of Echinococcus granulosus from humans and herbivorous hosts in Iran using an integrated mutation scanning-phylogenetic approach.</title><summary type='text'> Electrophoresis. 2009 Jul 27; Sharbatkhori M, Mirhendi H, Jex AR, Pangasa A, Campbell BE, Kia EB, Eshraghian MR, Harandi MF, Gasser RBIn the present study, we have extended earlier taxonomic, biochemical and experimental investigations to characterize Echinococcus granulosus from various hosts in Iran utilizing DNA regions (designated pcox1 and pnad1) within the cytochrome c oxidase subunit 1 </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5935062113513840733'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/5935062113513840733'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/genetic-categorization-of-echinococcus.html' title='Genetic categorization of Echinococcus granulosus from humans and herbivorous hosts in Iran using an integrated mutation scanning-phylogenetic approach.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-4724020970938998520</id><published>2009-07-29T22:53:00.001-07:00</published><updated>2009-07-29T22:53:25.597-07:00</updated><title type='text'>Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.</title><summary type='text'> Antimicrob Agents Chemother. 2009 Jul 27; Schurek KN, Sampaio JL, Kiffer CR, Sinto S, Mendes CM, Hancock REWhen investigating susceptibility testing methods for polymyxins, 24 multidrug resistant clinical isolates of Pseudomonas aerugionsa were observed to have a distinct, reproducible phenotype in which skipped wells were observed during microbroth dilution testing for polymyxin B. Possible </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4724020970938998520'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4724020970938998520'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/involvement-of-pmrab-and-phopq-in.html' title='Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1295424966995777012</id><published>2009-07-29T17:28:00.001-07:00</published><updated>2009-07-29T17:28:49.488-07:00</updated><title type='text'>Histologically Bland "Extremely Well Differentiated" Thyroid Carcinomas Arising in Struma Ovarii can Recur and Metastasize.</title><summary type='text'> Int J Gynecol Pathol. 2009 May; 28(3): 222-30Garg K, Soslow RA, Rivera M, Tuttle MR, Ghossein RAStruma ovarii (SO) infrequently harbor carcinomas that are histologically similar to those arising in the eutopic thyroid. We identified 10 such cases in our files. Eight patients presented with pelvic-related symptoms whereas 2 were incidentally discovered during pregnancy, all with disease confined </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1295424966995777012'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1295424966995777012'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/histologically-bland-extremely-well.html' title='Histologically Bland &quot;Extremely Well Differentiated&quot; Thyroid Carcinomas Arising in Struma Ovarii can Recur and Metastasize.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1948773229590442478</id><published>2009-07-29T06:36:00.001-07:00</published><updated>2009-07-29T06:36:38.081-07:00</updated><title type='text'>Aicardi-Goutieres Syndrome: Neuroradiologic Findings and Follow-Up.</title><summary type='text'> AJNR Am J Neuroradiol. 2009 Jul 23; Uggetti C, La Piana R, Orcesi S, Egitto MG, Crow YJ, Fazzi EBACKGROUND AND PURPOSE: To date, few studies have focused specifically on imaging findings in Aicardi-GoutiÃ¨res syndrome (AGS). We set out to evaluate retrospectively neuroradiologic data from a large sample of patients with AGS, focusing on the pattern of white matter abnormalities and the temporal </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1948773229590442478'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1948773229590442478'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/aicardi-goutieres-syndrome.html' title='Aicardi-Goutieres Syndrome: Neuroradiologic Findings and Follow-Up.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7250453104972349348</id><published>2009-07-29T02:30:00.001-07:00</published><updated>2009-07-30T06:18:43.690-07:00</updated><title type='text'>Obturatory abscess and pelvic pain caused by Brucella melitensis]</title><summary type='text'>Brucellosis which is a systemic infection, is seen endemically in Turkey. Although there a lot of complications related to brucellosis, soft tissue involvement is rare. In this case report a patient with mature cystic teratoma and a Brucella related obturatory abscess, was presented.A 21-year-old female patient with bilateral pelvic pain was admitted to the hospital with complaints of weakness, </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7250453104972349348'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7250453104972349348'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/obturatory-abscess-and-pelvic-pain.html' title='Obturatory abscess and pelvic pain caused by Brucella melitensis]'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8782437003364460540</id><published>2009-07-28T23:25:00.001-07:00</published><updated>2009-07-30T06:01:12.744-07:00</updated><title type='text'>Dysfunctional Cystic Fibrosis Transmembrane Conductance Regulator</title><summary type='text'>Cystic fibrosis is caused by mutated cystic fibrosis transmembrane conductance regulator (CFTR), and is characterized by robust airway inflammation and accumulation of apoptotic cells.Phagocytosis of apoptotic cells (efferocytosis) is a pivotal regulator of inflammation, because it prevents post-apoptotic necrosis and actively suppresses release of a variety of pro-inflammatory mediators, </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8782437003364460540'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8782437003364460540'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/dysfunctional-cystic-fibrosis.html' title='Dysfunctional Cystic Fibrosis Transmembrane Conductance Regulator'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6461632698746096621</id><published>2009-07-28T18:55:00.001-07:00</published><updated>2009-07-28T18:55:46.732-07:00</updated><title type='text'>A truncated CFTR protein rescues endogenous {Delta}F508-CFTR and corrects chloride transport in mice.</title><summary type='text'> FASEB J. 2009 Jul 20; Cormet-Boyaka E, Hong JS, Berdiev BK, Fortenberry JA, Rennolds J, Clancy JP, Benos DJ, Boyaka PN, Sorscher EJCystic fibrosis (CF) is most frequently associated with deletion of phenylalanine at position 508 (DeltaF508) in the CF transmembrane conductance regulator (CFTR) protein. The DeltaF508-CFTR mutant protein exhibits a folding defect that affects its processing and </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6461632698746096621'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6461632698746096621'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/truncated-cftr-protein-rescues.html' title='A truncated CFTR protein rescues endogenous {Delta}F508-CFTR and corrects chloride transport in mice.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-860605153561645502</id><published>2009-07-28T17:30:00.001-07:00</published><updated>2009-07-28T17:30:20.076-07:00</updated><title type='text'>Need for lung resection in patients with intact or ruptured hydatid cysts.</title><summary type='text'> Thorac Cardiovasc Surg. 2009 Aug; 57(5): 295-302Vasquez JC, Montesinos E, Peralta J, Rojas L, DeLaRosa J, Leon JJBACKGROUND: Lung hydatid cyst caused by ECHINOCOCCUS GRANULOSUS is endemic in many areas of the world. We aimed to compare the outcome of surgical treatment in intact and ruptured (infected or noninfected) cysts. METHODS: We reviewed the medical records of 115 patients with lung </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/860605153561645502'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/860605153561645502'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/need-for-lung-resection-in-patients.html' title='Need for lung resection in patients with intact or ruptured hydatid cysts.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6035367248136197414</id><published>2009-07-28T07:34:00.001-07:00</published><updated>2009-07-28T07:34:13.772-07:00</updated><title type='text'>Single-lung transplantation in patients with previous contralateral pneumonectomy: technical aspects and results.</title><summary type='text'> Eur J Cardiothorac Surg. 2009 Jul 24; Le Pimpec-Barthes F, Thomas PA, Bonnette P, Mussot S, Defrancquen P, Hernigou A, LatrÃ©mouille C, Riquet MObjective: Single-lung transplantation (SLTX) in patients with previous contralateral pneumonectomy (PN) is a rarely observed situation. Intrathoracic anatomical changes caused by mediastinal shift may complicate the surgical procedure. We collected </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6035367248136197414'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6035367248136197414'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/single-lung-transplantation-in-patients.html' title='Single-lung transplantation in patients with previous contralateral pneumonectomy: technical aspects and results.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2247688208856915703</id><published>2009-07-27T23:42:00.001-07:00</published><updated>2009-07-27T23:42:18.212-07:00</updated><title type='text'>[Staphylococcus aureus hepatic abscess associated with cervical lymphadenitis]</title><summary type='text'> Mikrobiyol Bul. 2009 Apr; 43(2): 313-7DoÄan Celik A, YuluÄkural Z, KuloÄlu F, Akata FPyogenic liver abscesses usually develop secondary to biliary tract and intraabdominal infections and members of the Enterobacteriaceae family are usually implicated as the etiologic agents. In this report a case of hepatic abscess devoloped secondary to cervical lymphadenitis caused by Staphylococcus aureus,</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2247688208856915703'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2247688208856915703'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/staphylococcus-aureus-hepatic-abscess.html' title='[Staphylococcus aureus hepatic abscess associated with cervical lymphadenitis]'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8054621403017958591</id><published>2009-07-27T15:52:00.001-07:00</published><updated>2009-07-27T15:52:01.506-07:00</updated><title type='text'>[CT and MRI manifestations of pediatric presacral tumors.]</title><summary type='text'> Ai Zheng. 2009 Apr; 28(4): 420-4Fan M, Peng Q, Wang XY, Meng QF, Li ZPBackground and Objective: The imaging of presacral tumors in children is characteristic. Computed tomography (CT) and magnetic resonance imaging (MRI) have great values in identifying the position, contents and invasion of pediatric presacral tumors before operation. This study was to investigate the CT and MRI features of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8054621403017958591'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8054621403017958591'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/ct-and-mri-manifestations-of-pediatric.html' title='[CT and MRI manifestations of pediatric presacral tumors.]'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2923292522692205325</id><published>2009-07-26T23:31:00.001-07:00</published><updated>2009-07-26T23:31:55.430-07:00</updated><title type='text'>Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.</title><summary type='text'> PLoS Genet. 2009 Jul; 5(7): e1000575Vincent DF, Yan KP, Treilleux I, Gay F, Arfi V, Kaniewsky B, Marie JC, Lepinasse F, Martel S, Goddard-Leon S, Iovanna JL, Dubus P, Garcia S, Puisieux A, Rimokh R, Bardeesy N, Scoazec JY, Losson R, Bartholin LInactivation of the Transforming Growth Factor Beta (TGFbeta) tumor suppressor pathway contributes to the progression of Pancreatic Ductal AdenoCarcinoma </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2923292522692205325'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2923292522692205325'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/inactivation-of-tif1gamma-cooperates.html' title='Inactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2195675667488759412</id><published>2009-07-15T15:56:00.001-07:00</published><updated>2009-07-23T14:29:45.146-07:00</updated><title type='text'>Prevalent breast cancer patients with a homozygous mutant status</title><summary type='text'>Retrospective studies suggest that single nucleotide polymorphisms in the cytochrome P450 2D6 (CYP2D6) gene predict reduced tamoxifen metabolism, better tolerance and worse treatment outcome.We hypothesized that women with this genotype lack tamoxifen-induced endometrial and biochemical changes in follicle-stimulating hormone (FSH) and sex hormone-binding globulin (SHBG). We identified 56 breast </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2195675667488759412'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2195675667488759412'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/prevalent-breast-cancer-patients-with.html' title='Prevalent breast cancer patients with a homozygous mutant status'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-2650450691392879254</id><published>2009-07-15T15:35:00.001-07:00</published><updated>2009-07-15T15:35:11.537-07:00</updated><title type='text'>Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis.</title><summary type='text'> Pediatr Pulmonol. 2009 Jul 13; Robinson PD, Cooper P, Van Asperen P, Fitzgerald D, Selvadurai HBACKGROUND: The use of alternative more sensitive measures has become a focus of research in CF. The utility of indexes of ventilation, Lung Clearance Index (LCI) and peak aerobic capacity (peak VO(2)), were studied as assessment tools in gauging response to intravenous (IV) therapy in acute pulmonary </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2650450691392879254'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/2650450691392879254'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/using-index-of-ventilation-to-assess.html' title='Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-1054668605467249018</id><published>2009-07-15T03:48:00.001-07:00</published><updated>2009-07-15T03:48:54.475-07:00</updated><title type='text'>Management of Ovarian Dermoid Cysts in the Pediatric and Adolescent Population.</title><summary type='text'> J Pediatr Adolesc Gynecol. 2009 Jul 7; Savasi I, Lacy JA, Ted Gerstle J, Stephens D, Kives S, Allen LSTUDY OBJECTIVE: To evaluate the surgical approach used in the management of ovarian dermoid cysts in the pediatric and adolescent population. DESIGN: A descriptive retrospective chart review of all cases of ovarian dermoid cyst excision between January 2001 and January 2006. SETTING: The </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1054668605467249018'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/1054668605467249018'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/management-of-ovarian-dermoid-cysts-in.html' title='Management of Ovarian Dermoid Cysts in the Pediatric and Adolescent Population.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6320045152895531252</id><published>2009-07-14T15:22:00.001-07:00</published><updated>2009-07-14T15:22:03.711-07:00</updated><title type='text'>The recognition and treatment of growth disorders - A 50-year retrospective.</title><summary type='text'> Ann Hum Biol. 2009 Jul 10; 1-15Zemel BThe past 50 years have seen great progress in the understanding and treatment of classic growth disorders. Advances such as the recognition of hormone receptor defects, the development of recombinant growth hormone, and the expanding awareness of epigenetic phenomena affecting growth are among these great achievements. Yet growth failure remains a pervasive </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6320045152895531252'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6320045152895531252'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/recognition-and-treatment-of-growth.html' title='The recognition and treatment of growth disorders - A 50-year retrospective.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-4483699913164451272</id><published>2009-07-14T13:52:00.001-07:00</published><updated>2009-07-14T13:52:38.981-07:00</updated><title type='text'>Insulin Therapy to Improve BMI in Cystic Fibrosis Related Diabetes Without Fasting Hyperglycemia: Results of the CFRDT Trial.</title><summary type='text'> Diabetes Care. 2009 Jul 10; Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H,  Objective: Cystic fibrosis related diabetes (CFRD) without fasting hyperglycemia (FH-) is not associated with microvascular or macrovascular complications, leading to controversy about the need for treatment. The CFRD Therapy Trial (CFRDT) sought to determine whether diabetes </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4483699913164451272'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/4483699913164451272'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/insulin-therapy-to-improve-bmi-in.html' title='Insulin Therapy to Improve BMI in Cystic Fibrosis Related Diabetes Without Fasting Hyperglycemia: Results of the CFRDT Trial.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-90164488838640768</id><published>2009-07-14T05:36:00.001-07:00</published><updated>2009-07-14T05:36:36.076-07:00</updated><title type='text'>[Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification.]</title><summary type='text'> Ann Otolaryngol Chir Cervicofac. 2009 Jul 8; El Ayoubi A, Poizat F, Garrel R, Costes V, Guerrier B, Essakalli L, Kzadri M, Crampette LOBJECTIVES: The WHO 2005 histological classification separates sinonasal adenocarcinoma (ADC) into three classes: intestinal-type adenocarcinoma (ITAC), low-grade sinonasal ADC and high-grade sinonasal ADC. The goal of this study was to check the relevance of this</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/90164488838640768'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/90164488838640768'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/sinonasal-adenocarcinomas-reviewed.html' title='[Sinonasal adenocarcinomas reviewed. Prognostic value of WHO 2005 histological classification.]'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-6898614555102164735</id><published>2009-07-14T02:39:00.001-07:00</published><updated>2009-07-14T02:39:17.274-07:00</updated><title type='text'>N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.</title><summary type='text'> NMR Biomed. 2009 Jul 10; Kolwijck E, Engelke UF, van der Graaf M, Heerschap A, Blom HJ, Hadfoune M, Buurman WA, Massuger LF, Wevers RAAn unassigned and prominent resonance in the region from delta 2.0-2.1 ppm has frequently been found in the in vivo MR spectra of cancer patients. We demonstrated the presence of this resonance with in vivo MRS in the cyst fluid of a patient with an ovarian tumor.</summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6898614555102164735'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/6898614555102164735'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/n-acetyl-resonances-in-in-vivo-and-in.html' title='N-acetyl resonances in in vivo and in vitro NMR spectroscopy of cystic ovarian tumors.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-7814093149261143057</id><published>2009-07-13T20:45:00.001-07:00</published><updated>2009-07-13T20:45:50.978-07:00</updated><title type='text'>Life cycle and molecular phylogeny of the dinoflagellates Chytriodinium and Dissodinium, ectoparasites of copepod eggs.</title><summary type='text'> Eur J Protistol. 2009 Jul 7; GÃ³mez F, Moreira D, LÃ³pez-GarcÃ­a PThe dinoflagellates Chytriodinium affine, C. roseum and Dissodinium pseudolunula are ectoparasites of crustacean eggs. Here, we present new observations regarding their life cycle based on coastal plankton samples and incubations and analyze their molecular phylogeny using the small subunit ribosomal RNA gene (SSU rDNA) as a </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7814093149261143057'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/7814093149261143057'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/life-cycle-and-molecular-phylogeny-of.html' title='Life cycle and molecular phylogeny of the dinoflagellates Chytriodinium and Dissodinium, ectoparasites of copepod eggs.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-242342722006773754</id><published>2009-07-13T18:09:00.001-07:00</published><updated>2009-07-13T18:09:03.099-07:00</updated><title type='text'>Hepatic parenchyma resection using stapling devices: peri-operative and long-term outcome.</title><summary type='text'> HPB (Oxford). 2009; 11(1): 38-44Delis SG, Bakoyiannis A, Karakaxas D, Athanassiou K, Tassopoulos N, Manesis E, Ketikoglou I, Papakostas P, Dervenis CBACKGROUND: Stapler-assisted hepatectomy has not been well established, as a routine procedure, although few reports exist in the literature. This analysis assesses the safety and outcome of the method based on peri-operative data. MATERIALS AND </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/242342722006773754'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/242342722006773754'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/hepatic-parenchyma-resection-using.html' title='Hepatic parenchyma resection using stapling devices: peri-operative and long-term outcome.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-8307160854556092177</id><published>2009-07-13T14:10:00.001-07:00</published><updated>2009-07-13T14:10:14.428-07:00</updated><title type='text'>Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life.</title><summary type='text'> Environ Health Perspect. 2009 Jun; 117(6): 879-85Newbold RR, Jefferson WN, Padilla-Banks EBACKGROUND: Exposure to endocrine-disrupting chemicals during critical developmental periods causes adverse consequences later in life; an example is prenatal exposure to the pharmaceutical diethylstilbestrol (DES). Bisphenol A (BPA), an environmental estrogen used in the synthesis of plastics, is of </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8307160854556092177'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/8307160854556092177'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/prenatal-exposure-to-bisphenol-at.html' title='Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry><entry><id>tag:blogger.com,1999:blog-2302293904584925227.post-9062633153403609674</id><published>2009-07-12T18:22:00.001-07:00</published><updated>2009-07-12T18:22:22.157-07:00</updated><title type='text'>MRI findings of intracranial cystic meningiomas.</title><summary type='text'> Clin Radiol. 2009 Aug; 64(8): 792-800Zhang D, Hu LB, Zhen JW, Zou LG, Feng XY, Wang WX, Wen LAIM: To report the magnetic resonance imaging (MRI) features of intracranial cystic meningiomas and compare these features in intra- and peritumoural cyst groups. MATERIALS AND METHODS: Fourteen cases of peritumoural cystic meningiomas were compared with 18 cases of intratumoural cystic meningiomas. All </summary><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/9062633153403609674'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/2302293904584925227/posts/default/9062633153403609674'/><link rel='alternate' type='text/html' href='http://the-cystic-fibrosis.blogspot.com/2009/07/mri-findings-of-intracranial-cystic.html' title='MRI findings of intracranial cystic meningiomas.'/><author><name>Euwi-lan</name><uri>http://www.blogger.com/profile/15158956921812207419</uri><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='16' height='16' src='http://img2.blogblog.com/img/b16-rounded.gif'/></author></entry></feed>
